BridgeBio Oncology Therapeutics Inc.

NASDAQ:BBOT

Biotechnology

Healthcare
$1.86 -0.39%

-$0.03 today

Market cap
$149.27M
Beta
0.29
P/E (TTM)
-1.5
EPS (TTM)
-$4.95
52W Low $7.00High $14.87

Volume 0.37M

Average 0.37M

Price history

BridgeBio Oncology Therapeutics Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-85.33%

Period high

$13.69

Period low

$1.81

Latest

$1.86

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
SC 13G/ANov 13, 2026Nov 13, 2026
10-QNov 10, 2026Nov 10, 2026
8-KNov 10, 2026Nov 10, 2026
8-KNov 5, 2026Nov 5, 2026
4Oct 23, 2026Oct 23, 2026
4Oct 5, 2026Oct 5, 2026
4Oct 5, 2026Oct 5, 2026
4Oct 5, 2026Oct 5, 2026
4Oct 5, 2026Oct 5, 2026
4Sep 14, 2026Sep 14, 2026
EFFECTSep 10, 2026Sep 11, 2026
EFFECTSep 8, 2026Sep 9, 2026
8-KSep 8, 2026Sep 8, 2026
S-3Sep 1, 2026Sep 1, 2026
POS AMSep 1, 2026Sep 1, 2026

Competitors

Who does BridgeBio Oncology Therapeutics Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about BBOT's filings, answered from its disclosures.

What is the latest BBOT filing?

The latest filing shown is SC 13G/A dated Nov 13, 2026.

How many recent filings does BBOT have?

Intrinsic Alpha currently shows 20 recent filings for BBOT.